Publication | Closed Access

Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells

MedicineCervical Cancer CellsType 2PathologyFirst-line DrugSmall RnaTumor SuppressorMicrorna DetectionCancer BiologyCell BiologyCell SignalingTumor Microenvironment